Trial in progress (XALute): Phase 3 study of xaluritamig vs investigator’s choice of cabazitaxel or second androgen receptor directed therapy (ARDT) in post-taxane metastatic castration-resistant ...
Wellbeing Magazine on MSN
How selective androgen receptor modulators target muscle tissue
Selective Androgen Receptor Modulators, shortly called SARMs, are combined compounds made to work with the body's androgen receptors The post How Selective Androgen Receptor Modulators Target Muscle ...
Prostate cancer hijacks the normal prostate's growth regulation program to release the brakes and grow freely, according to Weill Cornell Medicine researchers. The discovery, published Dec. 13 in ...
Overall survival and quality of life with [177Lu] Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in poor-risk, metastatic, castration-resistant prostate cancer in ENZA-p (ANZUP 1901).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results